- We are the official journal of the Brazilian Diabetes Society, and we publish advances of broad interest across the fields of diabetes and metabolic syndrome, including animal and clinical research.
- Open access publication ensures that your article can be easily discovered, accessed, used and shared, maximising your impact and acting as a springboard for further discovery.
- By combining rigorous expert assessment with our extensive peer review network, we provide an efficient service with the highest standards.
- We deliver high levels of author satisfaction, with 97% of our published authors reporting that they would definitely or probably publish with us again.
Aims and scope
Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome.
By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a highly visible forum for new insights and discussions into the issues of importance to the relevant community.
The journal aims to help health care providers improve the management of people afflicted by these syndromes by increasing knowledge and stimulating research in the field.
Diabetology & Metabolic Syndrome reports on basic research and clinical studies in the areas of genetics, pathophysiology, immunology, epidemiology, clinical management, therapeutic strategies, education, nutrition and psychosocial research relevant for the study of diabetes and metabolic syndrome.
Why publish your article in Diabetology & Metabolic Syndrome?
All articles published by Diabetology & Metabolic Syndrome are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Diabetology & Metabolic Syndrome you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Diabetology & Metabolic Syndrome therefore levies an article-processing charge of £1990.00/$2790.00/€2290.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.
Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.
For more information on APCs please see our Journal Pricing FAQs
All articles published in Diabetology & Metabolic Syndrome are included in:
- Google Scholar
- PubMed Central
- Science Citation Index Expanded
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
Diabetology & Metabolic Syndrome operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
All manuscripts submitted to Diabetology & Metabolic Syndrome should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Diabetology & Metabolic Syndrome
Articles in Diabetology & Metabolic Syndrome should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Diabetology & Metabolic Syndrome [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Diabetology & Metabolic Syndrome 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
Authors who wish to appeal a rejection or make a complaint should follow the procedure outlined in the BMC Editorial Policies.
Benefits of publishing with BMC
Diabetology & Metabolic Syndrome's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Diabetology & Metabolic Syndrome offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Diabetology & Metabolic Syndrome gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Diabetology & Metabolic Syndrome are included in article alerts and regular email updates. Some may be highlighted on Diabetology & Metabolic Syndrome’s pages and on the BMC homepage.
In addition, articles published in Diabetology & Metabolic Syndrome may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Diabetology & Metabolic Syndrome. A list of articles recently press-released by journals published by BMC is available here.
As an author of an article published in Diabetology & Metabolic Syndrome you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).
For further information about the advantages of publishing in a journal from BMC, please click here.
The official journal of the Brazilian Diabetes Society.
Annual Journal Metrics
5.395 - 2-year Impact Factor (2021)
4.586 - 5-year Impact Factor (2021)
1.209 - SNIP (Source-Normalized Impact per Paper)
0.955- SJR (SCImago Journal Rank)
18 days to first decision for all manuscripts (Median)
44 days to first decision for reviewed manuscripts only (Median)
981,847 Downloads (2021)
440 Altmetric mentions (2021)